MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    5HTTLPR (44bp Ins/Del) polymorphism: Serotonergic subtype of Parkinson’s Disease

    T. Syed, R. Kandadai, S. Yaranagula, T. Sd, S. Mohareer, S. Kola, R. Alugolu, R. Borgohain (Hyderabad, India)

    Objective: To find out the association of 5HTTLPR (44bp Ins/Del) polymorphism with PD neurotransmitter subtypes Background: Parkinson’s Disease (PD) can be sub divided into serotonergic,…
  • 2024 International Congress

    The Protective Effect of Sutherlandia frutescens in a Rotenone-Induced Rat Model of Parkinson’s Disease.

    L. Darbinyan, L. Manukyan, K. Simonyan, L. Hovhannisyan, V. Sarkisian, L. Hambardzumyan (Yerevan, Armenia)

    Objective: The objective of this study was to investigate the impact of rotenone, a pesticide associated with Parkinson's-like symptoms, and Sutherlandia frutescens (SF), a plant…
  • 2024 International Congress

    Cervical Vestibular-Evoked Myogenic Potentials in Patients with Parkinson’s Disease

    E. Abed (Cairo, Egypt)

    Objective: to examine the functioning of the brain stem and to gain insight into the irregularities of cervical vestibular-evoked myogenic potentials (cVEMPs) in patients with…
  • 2024 International Congress

    Altered gut microbiota composition and metabolism in Parkinson’s disease

    D. Mondhe, K. Roper, N. Jayabalan, J. O'Sullivan, R. Adam, A. Lehn, R. Gordon (Brisbane, Australia)

    Objective: To define changes in gut microbiota composition and metabolism to enable identification of novel therapeutic targets and strategies for disease modification. Background: Multiple cohort…
  • 2024 International Congress

    Reduced plasma levels of various cell signaling molecules in patients with Parkinson’s Disease

    S. Zadegan, A. Teixeira, E. Furr Stimming, N. Pessoa Rocha (Housotn, USA)

    Objective: To define the profile of different cell signaling molecules in the blood of patients with Parkinson’s Disease (PD) compared to controls. Background: PD is…
  • 2024 International Congress

    Dynamic video-assessment of axial postural abnormalities in parkinsonism: feasibility and pilot analysis

    C. Geroin, C. Artusi, S. Camozzi, G. Imbalzano, S. Aldegheri, L. Lopiano, N. Bombieri, M. Tinazzi (Verona, Italy)

    Objective: To evaluate changes in the degree of axial postural abnormalities (APAs) using the AutoPosturePD software during standing and walking under single/dual-task conditions. Background: We…
  • 2024 International Congress

    Engage, Educate and Empower: Parkinson’s Research Advocates from the Black and African American Community

    R. Mills-Joseph, K. Gamble, T. Best, K. Williams, L. Wilson, D. Coley, B. Coley, M. Fitts, R. Huckabee, A. Huckabee, E. Lewis, L. Seghetti, C. Branson, H. Shah, A. Kumeh, C. Gallagher, C. Evers, E. Stevens (Columbus, USA)

    Objective: To assess engagement in research advocacy among Black and African people with Parkinson’s and their care partners. Background: Black and African American people with…
  • 2024 International Congress

    The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases

    J. Maple-Grødem, V. Frantzen, J. Lange, E. Fiske, E. Bjordal, V. Forsaa, ø. Kallevåg, J. Berge, A. Jimenez, P. Førland, D. Aarsland, G. Alves (Stavanger, Norway)

    Objective: The Pro-LBD cohort study is a prospective, long-term, clinic-biological cohort study of participants who are stratified by their risk of developing a Lewy body…
  • 2024 International Congress

    Impact of Prior Head Trauma on Parkinson’s Disease Experience

    S. Vallamkonda, A. Hohler (Boston, USA)

    Objective: We aim to characterize the impact of prior head trauma on Parkinson’s disease (PD) related outcomes. Background: Previous head trauma is correlated with detrimental…
  • 2024 International Congress

    Exploring Vestibulopathy in PD: Distinguishing PD from Age-related Presbyvestibulopathy via Dynamic Gait and Balance Assessment

    G. Carli, D. Mccaslin, T. Brown, S. David, J. Barr, R. Vangel, A. Luker, C. Pongmala, K. Kerber, N. Bohnen (Ann Arbor, USA)

    Objective: To investigate the influence of age-associated vestibulopathy (presbyvestibulopathy, PVP) on dynamic gait and balance in Parkinson's disease (PD) patients and elderly controls. We hypothesized…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley